Development
-
Aslan Pharmaceuticals selects PharmaNet/i3 as partner for oncology development
Aslan Pharmaceuticals has selected PharmaNet/i3 as a partner supporting the development of their oncology portfolio in Asia.
Development | 02 May 2012
-
Quintiles, Biofund to expand clinical development capabilities in Russia
Russian venture company (RVC), Biofund, and Quintiles announced an agreement to support expansion of clinical development services within the Russian Federation, the world’s ninth most populous country.
Development | 13 April 2012
-
Life Technologies appoints head of global research and development
Life Technologies announced that Alan B Sachs, MD, PhD, former vice president, exploratory and translational sciences for Merck Research Laboratories, has joined the company as head of global research and development.
Development | 11 April 2012
-
GEA Pharma appoints director of sales, business development for Latin America
GEA Pharma Systems has appointed Zósimo López Moreno as its director sales and business development for Latin America.
Development | 22 March 2012
-
ICON Development Solutions appoints general manager of Asia Pacific
ICON announced that its development solutions division has appointed Dr Daniel Tang as general manager, Asia Pacific. Dr Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.
Development | 12 December 2011
-
Marinomed appoints head of development
Marinomed Biotechnologie, a company focused on the development of innovative therapies for respiratory diseases, announced that it has appointed Dr Angelika Bodenteich as the company’s head of development. Dr Bodenteich has also received commercial power of attorney.
Development | 31 October 2011
-
ICON selected as provider for early phase clinical development by BMS
ICON plc announced that it has been chosen by Bristol-Myers Squibb as a preferred provider for full-service clinical pharmacology and exploratory clinical studies. This latest agreement with Bristol-Myers-Squibb follows the company’s selection of I…
Development | 30 August 2011
-
Interest high for novel treatment options in development for metastatic breast cancer
Global oncology study highlights similarities, contrasts in treatment of breast cancer across the United States, Europe and Japan.
Development | 25 August 2011
-
Leading Japanese pharmaceutical scientists advance drug discovery and development
Research aims to deliver new paths to more effective drugs based on advancements in protein analysis.
Development | 08 August 2011
-
IVI and Inviragen announce collaboration to accelerate development of dengue vaccine
The International Vaccine Institute (IVI) and Inviragen Inc announced the signing of a memorandum of understanding with the ultimate objective of making a dengue vaccine widely accessible to people in countries where this disease is endemic. The IVI,…
Development | 04 August 2011
